Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies

Abstract Doxorubicin-induced cardiomyopathy (DOX-IC) is a significant and common complication in patients undergoing chemotherapy, leading to cardiac remodeling and reduced heart function. We hypothesized that the intrapericardial injection of hydrogels derived from the cardiac decellularized extrac...

Full description

Saved in:
Bibliographic Details
Main Authors: Tácia Tavares Aquinas Liguori, Gabriel Romero Liguori, Viktor Sinkunas, Cristiano Jesus Correia, Raphael dos Santos Coutinho e Silva, Fernando Luiz Zanoni, Vera Demarchi Aiello, Martin Conrad Harmsen, Luiz Felipe Pinho Moreira
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-87939-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571642755153920
author Tácia Tavares Aquinas Liguori
Gabriel Romero Liguori
Viktor Sinkunas
Cristiano Jesus Correia
Raphael dos Santos Coutinho e Silva
Fernando Luiz Zanoni
Vera Demarchi Aiello
Martin Conrad Harmsen
Luiz Felipe Pinho Moreira
author_facet Tácia Tavares Aquinas Liguori
Gabriel Romero Liguori
Viktor Sinkunas
Cristiano Jesus Correia
Raphael dos Santos Coutinho e Silva
Fernando Luiz Zanoni
Vera Demarchi Aiello
Martin Conrad Harmsen
Luiz Felipe Pinho Moreira
author_sort Tácia Tavares Aquinas Liguori
collection DOAJ
description Abstract Doxorubicin-induced cardiomyopathy (DOX-IC) is a significant and common complication in patients undergoing chemotherapy, leading to cardiac remodeling and reduced heart function. We hypothesized that the intrapericardial injection of hydrogels derived from the cardiac decellularized extracellular matrix (dECM) loaded with adipose tissue-derived stromal cells (ASC) and their secretome dampens or reverses the progression of DOX-IC. DOX-IC was induced in Wistar male rats through ten weekly intra-peritoneal injections of doxorubicin (cumulative dose: 18 mg/kg). We performed intrapericardial treatment in week five with dECM hydrogel loaded with ASC and their conditioned medium (CMed). The volume of intrapericardial injection was 2 ml/kg, the ASC density was 20 million/mL, while the hydrogel contained 100-fold concentrated CMed. Interstitial myocardial fibrosis was assessed by PicroSirius Red staining and hemodynamics parameters in pressure-volume loops. Compared to saline controls, interstitial myocardial fibrosis was reduced in ASC/CMed-loaded hydrogels treated animals (p = 0.0139). Ejection fraction and cardiac work efficiency improved in the ASC/CMed-treated rats compared to saline treatment (p = 0.0151 and p = 0.0655, respectively). The intrapericardial injection of dECM hydrogels loaded with ASC and their secretome warrants a novel therapeutic modality to improve ventricular hemodynamics and reduce cardiac remodeling in DOX-IC.
format Article
id doaj-art-33676e1635944e10a80aa6e43de06e7f
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-33676e1635944e10a80aa6e43de06e7f2025-02-02T12:24:44ZengNature PortfolioScientific Reports2045-23222025-01-0115111610.1038/s41598-025-87939-zIntrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathiesTácia Tavares Aquinas Liguori0Gabriel Romero Liguori1Viktor Sinkunas2Cristiano Jesus Correia3Raphael dos Santos Coutinho e Silva4Fernando Luiz Zanoni5Vera Demarchi Aiello6Martin Conrad Harmsen7Luiz Felipe Pinho Moreira8Instituto do Coração (InCor), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São PauloInstituto do Coração (InCor), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São PauloInstituto do Coração (InCor), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São PauloInstituto do Coração (InCor), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São PauloInstituto do Coração (InCor), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São PauloInstituto do Coração (InCor), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São PauloInstituto do Coração (InCor), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São PauloDepartment of Pathology and Medical Biology, University of Groningen and University Medical Center GroningenInstituto do Coração (InCor), Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São PauloAbstract Doxorubicin-induced cardiomyopathy (DOX-IC) is a significant and common complication in patients undergoing chemotherapy, leading to cardiac remodeling and reduced heart function. We hypothesized that the intrapericardial injection of hydrogels derived from the cardiac decellularized extracellular matrix (dECM) loaded with adipose tissue-derived stromal cells (ASC) and their secretome dampens or reverses the progression of DOX-IC. DOX-IC was induced in Wistar male rats through ten weekly intra-peritoneal injections of doxorubicin (cumulative dose: 18 mg/kg). We performed intrapericardial treatment in week five with dECM hydrogel loaded with ASC and their conditioned medium (CMed). The volume of intrapericardial injection was 2 ml/kg, the ASC density was 20 million/mL, while the hydrogel contained 100-fold concentrated CMed. Interstitial myocardial fibrosis was assessed by PicroSirius Red staining and hemodynamics parameters in pressure-volume loops. Compared to saline controls, interstitial myocardial fibrosis was reduced in ASC/CMed-loaded hydrogels treated animals (p = 0.0139). Ejection fraction and cardiac work efficiency improved in the ASC/CMed-treated rats compared to saline treatment (p = 0.0151 and p = 0.0655, respectively). The intrapericardial injection of dECM hydrogels loaded with ASC and their secretome warrants a novel therapeutic modality to improve ventricular hemodynamics and reduce cardiac remodeling in DOX-IC.https://doi.org/10.1038/s41598-025-87939-zDilated cardiomyopathy (DCM)DoxorubicinExtracellular matrixHydrogelsStem cellsCell therapy
spellingShingle Tácia Tavares Aquinas Liguori
Gabriel Romero Liguori
Viktor Sinkunas
Cristiano Jesus Correia
Raphael dos Santos Coutinho e Silva
Fernando Luiz Zanoni
Vera Demarchi Aiello
Martin Conrad Harmsen
Luiz Felipe Pinho Moreira
Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
Scientific Reports
Dilated cardiomyopathy (DCM)
Doxorubicin
Extracellular matrix
Hydrogels
Stem cells
Cell therapy
title Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
title_full Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
title_fullStr Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
title_full_unstemmed Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
title_short Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
title_sort intrapericardial injection of hydrogels with asc and their secretome to treat dilated cardiomyopathies
topic Dilated cardiomyopathy (DCM)
Doxorubicin
Extracellular matrix
Hydrogels
Stem cells
Cell therapy
url https://doi.org/10.1038/s41598-025-87939-z
work_keys_str_mv AT taciatavaresaquinasliguori intrapericardialinjectionofhydrogelswithascandtheirsecretometotreatdilatedcardiomyopathies
AT gabrielromeroliguori intrapericardialinjectionofhydrogelswithascandtheirsecretometotreatdilatedcardiomyopathies
AT viktorsinkunas intrapericardialinjectionofhydrogelswithascandtheirsecretometotreatdilatedcardiomyopathies
AT cristianojesuscorreia intrapericardialinjectionofhydrogelswithascandtheirsecretometotreatdilatedcardiomyopathies
AT raphaeldossantoscoutinhoesilva intrapericardialinjectionofhydrogelswithascandtheirsecretometotreatdilatedcardiomyopathies
AT fernandoluizzanoni intrapericardialinjectionofhydrogelswithascandtheirsecretometotreatdilatedcardiomyopathies
AT verademarchiaiello intrapericardialinjectionofhydrogelswithascandtheirsecretometotreatdilatedcardiomyopathies
AT martinconradharmsen intrapericardialinjectionofhydrogelswithascandtheirsecretometotreatdilatedcardiomyopathies
AT luizfelipepinhomoreira intrapericardialinjectionofhydrogelswithascandtheirsecretometotreatdilatedcardiomyopathies